KDM5A (also called JARID1A or RBP2) shows correlation with diverse human cancers, including tumors of the breast and lung (Blair et al. 2011; Teng et al. 2013, Yang et al. 2019, 2021a, b]. Here, KDM5A is linked to breast neoplasm.